Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117236) titled 'Comparing 2 medicines in Reducing Alcohol Cravings and Preventing Relapse' on Sept. 8.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Gullapalli Sai Ravi Teja
Condition:
Health Condition 1: G- Mental Health
Intervention:
Intervention1: Baclofen: a drug regularly used in patients with alcohol dependence syndrome as an anti-craving
starting with 10mg and hiking the dose until 60mg daily, per oral ro...